Diseases & Conditions
Grants & Contracts
News & Events
The ACTG NL consists of Core Laboratory groups in immunology, pharmacology, virology and TB.
The Markedly Accelerating Research with Knowledge of Tuberculosis Biomarkers (MARK-TB) has created a collaborative biobank in order to accelerate the development of new drugs and treatments for tuberculosis by validating and exploring biomarkers of response to TB drug treatments. The biobank will
The National Institutes of Health (NIH) HIV Reagent Program provides critical research reagents and resources to the scientific community.